Description
A potent, irreversible inhibitor of EGFR kinase activity (IC50 = 370 pM); halts cell cycling in cells that overexpress EGFR or c-ErbB2 (IC50s = 31-125 nM); profoundly blocks the growth of EGFR-overexpressing tumors in nude mice when given orally at 80 mg/kg/day for 10 days
Formal name: N-[4-[(3-bromophenyl)amino]-6-quinazolinyl]-2-butynamide
Synonyms: EKB-785|EKI-785|WAY-EKI-785
Molecular weight: 381.2
CAS: 194423-06-8
Purity: ≥95%
Formulation: A crystalline solid
Product Type|Biochemicals|Kinase Inhibitors|EGFR/ErbB/HER Family||Product Type|Biochemicals|Small Molecule Inhibitors|Kinases||Research Area|Cancer|Cell Cycle||Research Area|Cancer|Cell Signaling|Growth Factor Receptor Signaling||Research Area|Cell Biology|Cell Cycle||Research Area|Cell Biology|Cell Signaling|Growth Factor Receptors